BioSpace News Archive

Cyclerion Therapeutics, Inc. announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20, effective as of 5:00 p.m. Eastern Time on May 15, 2023.

Abivax (Euronext Paris: FR0012333284 - ABVX) informs its shareholders that its ordinary and extraordinary general meeting will be held on June 5, 2023, at 10:00 am (CEST), at the offices of Dechert (Paris) LLP, located at 22 rue Bayard in Paris (75008), France.

PHC Corporation of North America, supplier of the PHCbi brand of cell preservation and growth products in the North America and Latin America markets, is pleased to announce that the PHCbi brand VIP ECO® SMART ultra-low temperature freezer has been awarded the prestigious Outstanding New Product Award for 2023 by the International Society for Biological and Environmental Repositories.

Oxurion NV, a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, held its annual shareholders’ meeting on May 2, 2023.

Spear Bio co-founder, President & CTO, Feng Xuan, Ph.D. will be presenting at the upcoming Vaccines Summit at the Boston Marriott Newton Hotel.

As the need for more advanced technology continues to grow, TGH Imaging is increasing patient access across four counties for breast cancer screening by adding Genius™ 3D Mammography™ exams made by Hologic to 18 locations in Hillsborough, Pasco, Pinellas and Palm Beach counties.

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the first quarter ending March 31, 2023 and provided a business update.

Today, Juno Pharmaceuticals Canada announced the acquisition of Omega Laboratories (“Omega”), one of Canada’s largest domestic specialty injectable pharmaceutical manufacturers.

Spruce Biosciences, Inc today reported financial results for the quarter ended March 31, 2023 and provided corporate updates.

IceCure Medical Ltd. today announced that it will release its financial and operational results for the three months ended March 31, 2023.